Sign In
Buy GEHC
$62.03
+0.0400 (+0.0645%)
At Close: Jun 03, 2026
What Makes GE HealthCare (GEHC) a New Strong Buy Stock
01:00pm, Monday, 04'th Aug 2025
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GEHC vs. BSX: Which Stock Is the Better Value Option?
12:41pm, Friday, 01'st Aug 2025
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value inve
GE HealthCare: This Drop Represents A Buying Opportunity
03:48am, Thursday, 31'st Jul 2025
GE HealthCare Technologies delivered strong Q2 results, beating revenue and earnings expectations, and raised full-year guidance despite a sharp share price drop. The company is trading at a significa
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
01:56pm, Wednesday, 30'th Jul 2025
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
11:33am, Wednesday, 30'th Jul 2025
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
10:36am, Wednesday, 30'th Jul 2025
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics comp
GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
09:10am, Wednesday, 30'th Jul 2025
GE HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year.
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
08:31am, Wednesday, 30'th Jul 2025
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1 per share a year ago.
GE HealthCare raises annual profit forecast on smaller tariff impact
07:32am, Wednesday, 30'th Jul 2025
GE HealthCare Technologies raised annual profit forecast on Wednesday, as the medical device maker expects a smaller hit from tariffs.
GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.
07:10am, Wednesday, 30'th Jul 2025
Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.
GE HealthCare reports second quarter 2025 financial results
06:20am, Wednesday, 30'th Jul 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We were pleas
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
01:40pm, Monday, 28'th Jul 2025
GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
12:30pm, Thursday, 24'th Jul 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high
AI Chat With Roland Rott, President & CEO of Imaging at GE HealthCare
12:23am, Thursday, 24'th Jul 2025
In this podcast Motley Fool analysts David Meier and Asit Sharma and GE HealthCare's CEO of Imaging, Roland Rott, discuss:
GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA's list of AI authorizations for 4th Year with 100
08:00am, Wednesday, 23'rd Jul 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 liste
